Literature DB >> 30727767

Compliance with the prescription of recommended medical therapy in trials comparing six versus 12 months or longer dual antiplatelet therapy: A systematic review and meta-analysis.

Safi U Khan1, Muhammad Shahzeb Khan2, Edo Kaluski3, Mohamad A Alkhouli1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30727767      PMCID： PMC7457427          DOI： 10.1177/2047487319829947

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN： 2047-4873            Impact factor:   7.804


× No keyword cloud information.
  7 in total

1.  Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial.

Authors:  Marco Valgimigli; Gianluca Campo; Monia Monti; Pascal Vranckx; Gianfranco Percoco; Carlo Tumscitz; Fausto Castriota; Federico Colombo; Matteo Tebaldi; Giuseppe Fucà; Moh'd Kubbajeh; Elisa Cangiano; Monica Minarelli; Antonella Scalone; Caterina Cavazza; Alice Frangione; Marco Borghesi; Jlenia Marchesini; Giovanni Parrinello; Roberto Ferrari
Journal:  Circulation       Date:  2012-03-21       Impact factor: 29.690

2.  Compliance With Guideline-Directed Medical Therapy in Contemporary Coronary Revascularization Trials.

Authors:  Ana-Catarina Pinho-Gomes; Luis Azevedo; Jung-Min Ahn; Seung-Jung Park; Taye H Hamza; Michael E Farkouh; Patrick W Serruys; Milan Milojevic; Arie Pieter Kappetein; Gregg W Stone; Andre Lamy; Valentin Fuster; David P Taggart
Journal:  J Am Coll Cardiol       Date:  2018-02-13       Impact factor: 24.094

3.  Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study.

Authors:  Hyeon-Cheol Gwon; Joo-Yong Hahn; Kyung Woo Park; Young Bin Song; In-Ho Chae; Do-Sun Lim; Kyoo-Rok Han; Jin-Ho Choi; Seung-Hyuk Choi; Hyun-Jae Kang; Bon-Kwon Koo; Taehoon Ahn; Jung-Han Yoon; Myung-Ho Jeong; Taek-Jong Hong; Woo-Young Chung; Young-Jin Choi; Seung-Ho Hur; Hyuck-Moon Kwon; Dong-Woon Jeon; Byung-Ok Kim; Si-Hoon Park; Nam-Ho Lee; Hui-Kyung Jeon; Yangsoo Jang; Hyo-Soo Kim
Journal:  Circulation       Date:  2011-12-16       Impact factor: 29.690

4.  ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting.

Authors:  Stefanie Schulz-Schüpke; Robert A Byrne; Jurrien M Ten Berg; Franz-Josef Neumann; Yaling Han; Tom Adriaenssens; Ralph Tölg; Melchior Seyfarth; Michael Maeng; Bernhard Zrenner; Claudius Jacobshagen; Harald Mudra; Eberhard von Hodenberg; Jochen Wöhrle; Dominick J Angiolillo; Barbara von Merzljak; Nonglag Rifatov; Sebastian Kufner; Tanja Morath; Antonia Feuchtenberger; Tareq Ibrahim; Paul W A Janssen; Christian Valina; Yi Li; Walter Desmet; Mohamed Abdel-Wahab; Klaus Tiroch; Christian Hengstenberg; Isabell Bernlochner; Marcus Fischer; Heribert Schunkert; Karl-Ludwig Laugwitz; Albert Schömig; Julinda Mehilli; Adnan Kastrati
Journal:  Eur Heart J       Date:  2015-01-23       Impact factor: 29.983

5.  Impact of switching from different treatment regimens to a fixed-dose combination pill (polypill) in patients with cardiovascular disease or similarly high risk.

Authors:  Melvin Lafeber; Wilko Spiering; Frank Lj Visseren; Diederick E Grobbee; Michiel L Bots; Alice Stanton; Anushka Patel; Dorairaj Prabhakaran; Ruth Webster; Simon Thom; Anthony Rodgers
Journal:  Eur J Prev Cardiol       Date:  2017-03-08       Impact factor: 7.804

6.  6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial.

Authors:  Joo-Yong Hahn; Young Bin Song; Ju-Hyeon Oh; Deok-Kyu Cho; Jin Bae Lee; Joon-Hyung Doh; Sang-Hyun Kim; Jin-Ok Jeong; Jang-Ho Bae; Byung-Ok Kim; Jang Hyun Cho; Il-Woo Suh; Doo-Il Kim; Hoon-Ki Park; Jong-Seon Park; Woong Gil Choi; Wang Soo Lee; Jihoon Kim; Ki Hong Choi; Taek Kyu Park; Joo Myung Lee; Jeong Hoon Yang; Jin-Ho Choi; Seung-Hyuk Choi; Hyeon-Cheol Gwon
Journal:  Lancet       Date:  2018-03-12       Impact factor: 79.321

7.  Time to improve statin prescription guidelines in low-risk patients?

Authors:  Jan W Balder; Jeroen K de Vries; Douwe J Mulder; Pieter W Kamphuisen
Journal:  Eur J Prev Cardiol       Date:  2017-03-14       Impact factor: 7.804
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.